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Background: A deletion mutation in the growth hormone receptor (GHR) gene results in the inhibition of skeletal
muscle growth and fat deposition in dwarf chickens. We used microarray techniques to determine microRNA
(miRNA) and mRNA expression profiles of GHR in the skeletal muscles of 14-day-old embryos as well as 7-week-old
deletion-type dwarf and normal-type chickens. Our aim was to elucidate the miRNA regulation of GHR expression
with respect to growth inhibition and fat deposition.
Results: At the same developmental stages, different expression profiles in skeletal muscles of dwarf and normal
chickens occurred for four miRNAs (miR-1623, miR-181b, let-7b, and miR-128). At different developmental stages, there
was a significant difference in the expression profiles of a greater number of miRNAs. Eleven miRNAs were up-
regulated and 18 down-regulated in the 7-week-old dwarf chickens when compared with profiles in 14-day-old
embryos. In 7-week-old normal chickens, seven miRNAs were up-regulated and nine down-regulated compared with
those in 14-day-old embryos. In skeletal muscles, 22 genes were up-regulated and 33 down-regulated in 14-day-old
embryos compared with 7-week-old dwarf chickens. Sixty-five mRNAs were up-regulated and 108 down-regulated in
14-day-old embryos as compared with 7-week-old normal chickens. Thirty-four differentially expressed miRNAs were
grouped into 18 categories based on overlapping seed and target sequences. Only let-7b was found to be
complementary to its target in the 3′ untranslated region of GHR, and was able to inhibit its expression. Kyoto
Encyclopedia of Genes and Genomes pathway analysis and quantitative polymerase chain reactions indicated there
were three main signaling pathways regulating skeletal muscle growth and fat deposition of chickens. These were
influenced by let-7b-regulated GHR. Suppression of the cytokine signaling 3 (SOCS3) gene was found to be involved in
the signaling pathway of adipocytokines.
Conclusions: There is a critical miRNA, let-7b, involved in the regulation of GHR. SOCS3 plays a critical role in regulating
skeletal muscle growth and fat deposition via let-7b-mediated GHR expression.Background
The complete growth and development of chickens is mainly
dependent on the “hypothalamus-pituitary-target organ” path-
way [1,2]. Depending on the needs of the body, the hypothal-
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reproduction in any medium, provided the orsomatostatin. These play dual roles in the modulation and
control of pituitary and growth hormone (GH) secretion [3,4].
GH circulates back to the liver via the blood and complexes
with the GH receptor (GHR) on the liver cell surface to initi-
ate intracellular signaling mechanisms that promote the ex-
pression of insulin-like growth factors (IGFs). IGFs circulate
to the local tissues of the body through the bloodstream and
promote cell growth and differentiation [5].
Skeletal muscle is the major target organ of GH. GH
can act directly on the GHRs of skeletal muscle, produ-
cing paracrine and autocrine IGF-1 to regulate muscle
growth and development [6,7]. Hodik and Vasilatos-This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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etal muscle cell proliferation and differentiation, regu-
lates skeletal muscle abundance, and is involved in
muscle metabolic regulation [8,9]. GHR is part of the
GH-GHR-IGF growth axis, which regulates the expres-
sion of IGFs by mediating GH. Thus, it plays a role in
regulating skeletal muscle growth and development.
Studies indicate that the sex-linked dwarf chicken
(SLD) phenotype is caused by a mutation in the GHR
gene. Point and deletion mutations, structural gene
mutations, and mutations within the GHR regulatory
region are all thought to be involved in conferring
the SLD phenotype [10-13]. Of all these types of
mutations, the deletion mutation is believed to be the
main cause of this phenotype. Agarwal et al. found
that that the deletion mutation exhibited a 1.7-kb de-
letion between exon 10 and the 3' untranslated region
(3' UTR) of GHR [10]. The mutation results in a de-
crease in the number of muscle fibers and fiber
diameter [11]. Dwarf chickens also present with
increased carcass lipid content, which could be a re-
sult of increased lipogenesis and decreased energy ex-
penditure [14]. Another study suggested that in laying
hens, dwarfism reduces the adipose tissue lipid
mobilization and likely also reduces de novo lipogen-
esis in the liver [15]. Expression of GHR mRNA is
significantly up-regulated in dwarf chickens compared
with normal chickens [16].
Dwarf phenotypes have been found in humans, mice,
cattle, pigs, and other mammals [2,17-19]. Among them,
the most studied is Laron syndrome in humans. Laron
syndrome is familial dwarfism that was first reported in
1966, in which the serum GH level is normal, but IGF-1
levels are low [17]. Many studies have indicated that
most cases of human Laron syndrome are caused by
defects in GHR. Various types of mutations have been
noted in GHR, leading to GHR extra-cellular domain in-
activation. All of these can affect the binding of GHR
and GH, and leads to interruption of GH signal trans-
duction and a subsequent inability for GH to play its
normal role [20-29].
Karen et al. found that the lifespan of mice was signifi-
cantly prolonged after GHR was knocked out, but that
growth was retarded. While IGF-1, IGFBP-1, IGFBP-3,
and IGFBP-4 levels were significantly lower, IGFBP-2
levels were significantly increased, indicating that GHR
defects led to GH signal transduction obstruction, signifi-
cantly affecting phenotype [30]. Mavalli et al. found that
defective skeletal muscle development in both GHR and
IGF-1R mutants was attributable to diminished myoblast
fusion and associated with compromised nuclear factor
import and activity in activated T cells. Both mutants
exhibited impaired skeletal muscle development, charac-
terized by reductions in myofiber number and area as wellas accompanying deficiencies in functional performance
[31].
The above studies indicated that mutations in GHR
could lead to the obstruction of normal human and
animal skeletal muscle growth and fat deposition by
causing GH signal transduction obstruction. However,
the molecular mechanisms underlying the expression
of GHR and its regulation of chicken skeletal muscle
growth and fat deposition remain unclear.
Recently microRNAs (miRNAs) have been reported to be
widespread endogenous noncoding RNA molecules
involved in the regulation of gene expression [32,33]. In
cells, miRNAs pair with a complementary target sequence
in target mRNA 3' UTR to mediate the regulation of target
gene expression [34]. These miRNAs are thought be
involved in a series of important life processes, including
development, neural differentiation, cell proliferation, cell
apoptosis and fat metabolism [35]. Using the loss- and gain-
of-function method, Kwon et al. showed that miRNA-1 of
the ancient muscle-specific gene in Drosophila regulates
functions of the heart and muscle-specific genes via their
interaction with members of the Notch signaling pathway
[36]. Clop et al. found that a point mutation within the 3'
UTR of GDF8 in Texel sheep resulted in a target site that
allowed miR-1 and miR-206 to act simultaneously. This
caused a reduction in the expression of the miRNA-
mediated myostatin gene (MSTN) post-transcriptionally,
leading to muscle hypertrophy [37]. Chen et al. demon-
strated that miR-1 promotes differentiation of myoblasts
into mature muscle cells by acting on HDAC4, inhibiting
myoblast proliferation. The miRNA miR-133 promotes
myoblast proliferation through the SRF gene, inhibiting
myoblast differentiation [38]. These studies have suggested
that there is further scope for understanding molecular
mechanisms that regulate GHR expression.
In our study, we applied microarray technology to de-
termine the miRNA and mRNA expression profiles in
the skeletal muscles of dwarf and normal chickens at
different stages of development. Critical miRNAs asso-
ciated with GHR expression and the ways in which they
regulate skeletal muscle growth and fat deposition were
identified.
Results
Differential miRNA expression profiles in skeletal muscle
of dwarf and normal chickens
Using signal values greater than 32 as the standard, a
total of 124 miRNAs were detected in 22.9% of skeletal
muscles of 14-day-old embryos from dwarf chickens. In
normal chickens, 125 miRNAs were detected at a rate of
23.1%. At 7 weeks of age, 115 miRNAs were detected in
the skeletal muscles of dwarf chickens at a detection rate
of 21.2%, with 116 miRNAs detected in the skeletal mus-
cles of normal chickens (21.4%).
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miRNAs between the two different types of chickens
(Table 1). In 14-day-old embryos, expression of both miR-
1623 and miR-181b was significantly down-regulated in
dwarf chickens compared with normal chickens. Expres-
sion of let-7b and miR-128 in 7-week-old chickens was sig-
nificantly up-regulated and down-regulated, respectively.
Differential miRNA expression profiles in skeletal muscle
at different developmental stages
Expression of 11 miRNAs was up-regulated and 18 miR-
NAs down-regulated in 7-week-old dwarf chickens as
compared with 14-day-old embryos. Expression of seven
miRNAs was up-regulated and nine miRNAs down-
regulated in normal 7-week-old chickens compared with
14-day-old embryos. Of the differentially expressed miR-
NAs, expression of let-7b, miR-30a-5p, miR-30b, miR-
99a, and miR-133b was commonly up-regulated in both
dwarf and normal chickens. The expression of miR-16c,
miR-92, miR-106, miR-203, miR-451, and miR-454 was
commonly down-regulated (Table 2).
Differential mRNA expression profiles in skeletal muscle
of dwarf and normal chickens
A total of 38,535 probes were used to detect mRNA, of
which the probes displaying hybridization signals repre-
sented approximately 42.6–45.6% of the total. Probes
lacking hybridization signals represented approximately
52.8–55.7% of the total, with 1.5–1.7% ambiguous
hybridization signals. Using the normal chickens as a
control group, screening of the differentially expressed
genes in skeletal muscles was carried out using Signifi-
cance Analysis of Microarrays (SAM) software. The
screening criteria for signaling pathway analysis were
that the q-value (%) was less than 5% and it showed a
fold-change less than 2 (Additional file 1: Table S1).
The differential profiles in the skeletal muscle mRNA of
the 14-day-old embryos showed that there were 55 genes
with a greater than 2-fold change in differential expression
between the dwarf and normal chickens. Of these, 33 were
up-regulated and 22 were down-regulated. At 7 weeks,
173 genes had a greater than 2-fold change in differential
expression between dwarf and normal chickens, with 108
mRNAs up-regulated and 65 down-regulated.Table 1 The miRNA differential expression profiles of 14-day-
dwarf and normal chickens
Developmental stage miRNA Normal chickens
14-day-old embryos miR-1623 4,755 ± 837
miR-181b 7,741 ± 900
7-week-old chickens let-7b 6,137 ± 345
miR-128 1,455 ± 108
Note: Fold change means the change in let-7b’s expression as compared normal wiFurther comparisons between 14-day-old embryos and 7-
week-old normal and dwarf chickens indicated consistent
up-regulation in the mRNA expression levels of five genes:
ARNT, BEAN, HSCB, LOC770114, and RCJMB04_1j22.
There were three genes, GHR, LOC772190, and TMEM70
that presented with consistent down-regulation in normal
chickens but consistent up-regulation in dwarf chickens.
The mRNA expression of GHR in 14-day-old embryos of
dwarf chickens was up-regulated 3.57-fold compared with
normal chickens, and was up-regulated 5.26-fold in 7-week-
old dwarf chickens as compared with normal chickens.Analysis of miRNA target genes and differentially
expressed mRNA genes
Among the 34 differentially expressed miRNAs, there
were some with the same seed sequence and target
genes. This allowed for the classification of the miRNAs
into 18 categories. There were another five miRNAs in
which the target genes had not yet been discovered. The
prediction results of the various types of differentially
expressed miRNA target genes are shown in Additional
file 2: Table S2.
We compared various differentially expressed miRNA
prediction target genes with differentially expressed
mRNA of genes from 7-week-old chicken skeletal muscle.
In total, corresponding differentially expressed genes
were found for 14 types of miRNAs (Additional file 3:
Table S3). GHR was affected by let-7b, miR-15c, miR-16,
and miR-16c.Let-7b-mediated regulation of GHR expression
The miRNAs involved in the regulation of GHR were
let-7b, miR-15c (miR-16, miR-16c), and miR-181b
(Additional file 3: Table S3). BLAST analysis indicated
that the last 29 bp of the GHR 3' UTR exactly coincided
with the target site of let-7b. This is consistent with the
proposed mechanism of miRNAs as mainly targeting
the 3' UTR of target genes. However, the target sites of
miR-15c, miR-16, miR-16c and miR-181b were far
apart from the GHR region. Expression levels of let-7b
were significantly up-regulated in both dwarf and nor-
mal chickens at both stages of development investi-
gated (Table 2).old embryos and 7-week-old chickens skeletal muscle of
Dwarf chickens Fold changes p-value
2,184 ± 302 2.18 8.53E-03
5,284 ± 588 1.46 2.76E-02
6,992 ± 299 0.88 4.77E-02
1,177 ± 99 1.24 4.87E-02
th dwarf chickens.
Table 2 Differential miRNA expression profiles of skeletal muscle at different developmental stages as compared the
7-week-old chickens with the 14-day-old embryos
miRNA Dwarf chickens Normal-type chickens
Up-regulated let-7b, miR-24, miR-30a-5p, miR-30b, miR-30d, miR-99a, miR-100,
miR-133a, miR-133b, miR-133c, miR-146b
let-7b, miR-30a-5p, miR-30b, miR-30c,
miR-99a, miR-126, miR-133b
Down-regulated miR-15c, miR-16c, miR-17-5p, miR-20a, miR-20b, miR-21,
miR-92, miR-106, miR-130b, miR-181b, miR-200b, miR-203,
miR-205a, miR-206, miR-451, miR-454, miR-1576, miR-1777
miR-16, miR-16c, miR-92, miR-106, miR-199*,
miR-203, miR-451, miR-454, miR-1579
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Assuming that the dwarf chicken phenotype in this ex-
periment was caused by a deletion mutation in GHR, we
used the Kyoto Encyclopedia of Genes and Genomes
(KEGG) software (http://www.genome.jp/kegg/) to con-
duct a pathway analysis for GHR. The results indicated
that GHR is involved in the JAK-STAT signaling pathway
(Additional file 4: Figure S1).
The 111 genes involved in the JAK-STAT signaling
pathway have been summarized in Additional file 4:
Figure S1. These genes were compared with the differen-
tially expressed mRNAs in 7-week-old skeletal muscles
from dwarf and normal chickens. It was found that only
one gene, SOCS3, appeared in the mRNA expression
profiles. The KEGG software was also used to analyze
the signaling pathway of SOCS3 and was found to be
involved in the adipocytokine signaling pathway (Add-
itional file 5: Figure S2).
From the adipocytokine signaling pathway, it can be
seen that SOCS3 influences cellular regulation in three
ways: inhibiting the IRS1 gene through inhibition of the
phosphorylation of tyrosine in insulin receptor substrate 1
(IRS1) and thus inhibiting the insulin signalling pathway;
inhibiting the LEPR gene; and inhibiting the JAK gene.
Quantitative polymerase chain reaction (qPCR) analysis of
the GHR signaling pathway regulation by let-7b
Based on the previously mentioned analyses, a schematic
illustration of the GHR signaling pathway, as regulatedFigure 1 Schematic illustration of the signaling pathway of GHR regu
regulates SOCS3. SOCS3 regulates the growth and development of chicken
tyrosine in IRS1; inhibiting LEPR; and inhibiting JAK. IRS1, LEPR and JAK are inby let-7b, was developed (Figure 1). To verify the signal-
ing pathway, we carried out qPCR assays to determine
mRNA expression levels in the skeletal muscles of 7-
week-old dwarf and normal chickens. The qPCR analysis
showed that mRNA expression of GHR and SOCS3 was
up-regulated 4.24- and 2.95-fold, respectively in dwarf
chickens compared with normal chickens. The mRNA
expression of these genes was up-regulated 5.16- and
2.67-fold respectively, as shown by microarray analysis.
Expression of IRS1, LEPR and JAK2 was down-regulated
4.92-, 3.53- and 3.32-fold, respectively. The expression of
MYOD1, MyoG and Myf5, which regulate skeletal muscle
growth, was down-regulated 3.46-, 3.78- and 4.66-fold,
respectively, in dwarf chickens compared with normal
chickens. In addition, expression of IGF1 and
IGF2BP3 in the insulin pathway is also down-
regulated 6.73- and 3.97-fold respectively, in dwarf
compared with normal chickens (Figure 2).
Validation of the 3′ UTR of GHR as the target site of let-7b
Luciferase activity was decreased in DF-1 cell lines trans-
fected with pmirGLO-let-7b-GHR 3′ UTR (Figure 3A),
but increased in DF-1 cells transfected with pmirGLO-let-
7b-GHR 3′ UTR mutation, and in the control DF-1 cell
line (Figure 3 B and C). This confirms that the expression
of GHR is regulated by let-7b, and that the let-7b target is
located in the region of the GHR 3′ UTR mutation.
In the overexpression assay for let-7b, we observed it
was up-regulated 6.41-fold as compared with the control.lated by let-7b. miRNA let-7b inhibits the expression of GHR and
s through three signaling pathways: inhibiting the phosphorylation of
volved in growth, fat synthesis, and cell proliferation.
Figure 2 Validation of differentially expressed mRNA. When
comparing dwarf and normal chickens, the expression levels of
let-7b were significantly up-regulated. The mRNA expression levels of
GHR and SOCS3 were significantly up-regulated, but those of IRS1,
LEPR and JAK2 are significantly down-regulated. All mRNA expression
levels of MYOD1, MyoG and Myf5 regulating the growth of skeletal
muscle were significantly up-regulated in normal chickens, and
significantly down-regulated in dwarf chickens. The mRNA
expression levels of IGF1 and IGF2BP3, associated with the insulin
signaling pathway, were significantly down-regulated in dwarf
chickens.
Lin et al. BMC Genomics 2012, 13:306 Page 5 of 10
http://www.biomedcentral.com/1471-2164/13/1/306Conversely, expression of GHR was down-regulated
1.82-fold. Additionally, expression of SOCS3, stimulated
by GHR, was down-regulated 1.39-fold (Figure 4).
Discussion
miRNAs are a class of non-coding small RNA molecules
with a length of 18–24 nucleotides. They can direct the
regulation of the expression levels of certain genes, control
cell growth and development, and determine tissue type
during cell differentiation by reducing the stability of tar-
get genes or inhibiting translation levels to influence cell
differentiation, proliferation, and apoptosis. In animal
cells, miRNAs, by interacting with a specific sequence of
target gene mRNA, inhibit protein synthesis or induce
mRNA degradation and post-transcriptionally negatively
regulate the expression of target genes [39,40].Figure 3 Dual-luciferase reporter assay for validation of the 3′ UTR of
were transfected with pmirGLO-let-7b-GHR 3′ UTR, pmirGLO-let-7b-GHR 3′ U
luciferase (luc2) and Renilla luciferase (hRluc-neo) was measured and relativIn this study, high-throughput microarray technology
was used to analyze miRNA and mRNA expression pro-
files in the skeletal muscles of 14-day-old embryos and
7-week-old dwarf and normal chickens to identify miR-
NAs related to skeletal muscle growth and development.
In chickens, 499 pre-miRNAs and 544 mature-miRNAs
have been reported [41,42]. In the present study, 124
and 125 miRNAs were detected in the skeletal muscles
of 14-day-old embryos from dwarf and normal chickens,
respectively. We also detected 115 and 116 miRNAs in
the skeletal muscles of 7-week-old dwarf and normal
chickens, respectively. Such tissue-specific miRNA ex-
pression has been reported in a few previous studies
[41,43-46]. Our data also showed that there is signifi-
cantly different expression for only a few miRNAs at the
same developmental stages in dwarf and normal chick-
ens. However, the expression profiles of a greater num-
ber of miRNAs at different developmental stages for
dwarf and normal chickens were significantly different.
When comparing 7-week-old chickens with 14-day-old
embryos, more down-regulated miRNAs than up-
regulated miRNAs were detected. This would suggest
that down-regulated expression of miRNAs is favorable
for muscle growth and development in chickens at
7 weeks. In 7-week-old chickens, as compared with 14-
day-old embryos, the expression of let-7b, miR-30a-5p,
miR-30b, miR-99a and miR-133b was significantly up-
regulated, but miR-16c, miR-92, miR-106, miR-203, miR-
451 and miR-454 were significantly down-regulated in
both dwarf and normal chickens. Considering that
GH and GHR play important roles in chicken growth
and development, we focused on observing the miRNAs
involved in the regulation of their expression.
Four miRNAs, let-7b, miR-16, miR-16c, and miR-181b,
are involved in the regulation of GHR. BLAST analysis
confirmed that the target location of let-7b was in the
deleted region of GHR 3' UTR. But the target locations
of miR-16, miR-16c and miR-181b were distant from the
deleted region. We concluded that the regulation of
let-7b could be critical to GHR expression. As theGHR as the target site of the let-7b in vitro cell system. DF-1 cells
TR mutation plasmid, or the control plasmid. The activity of firefly
e values (luc2/hRluc-neo) calculated.
Figure 4 Functional validation of let-7b inhibiting GHR in an
in vitro cell system. pcDNA-EGFP-pre-let-7b was transfected into
the DF-1 cell line compared with cells transfected with the control
plasmid.
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of the ability of let-7b to pair with sequences in its
target gene, the regulation of growth and development
is affected.
Skeletal muscle growth and development in chickens is
fastest at the 7-week-old stage; conversely, the growth and
development of skeletal muscle during the embryonic
period is relatively slow. Comparing dwarf with normal
chickens, there was significantly different mRNA expres-
sion for 173 genes in the 7-week-old chickens; however,
there was significantly different mRNA expression for only
55 genes in the 14-day-old embryos. For both 14-day-old
embryos and 7-week-old chickens, mRNA expression of
GHR was up-regulated 3.57- and 5.26-fold, respectively, in
dwarf chickens compared with normal chickens. It is sug-
gested that the mRNA corresponding to GHR was inhib-
ited in normal chickens as reported by Wu et al. [16].
Comparing the different developmental stages (Table 2),
expression levels of let-7b were significantly up-regulated in
both dwarf and normal chickens. GHR expression was up-
regulated in dwarf chickens and down-regulated in normal
chickens, suggesting that let-7b could play a significant role
in inhibiting GHR expression, further promoting the growth
and development of skeletal muscle.
The let-7b miRNA is a member of the let-7 family.
Deletion, or mutation of the function of let-7, may lead
to defects in the transformation of nematodes from
their larval to adult stage [44]. Methylation, post-
translation modifications, and Lin28 genes regulate the
let-7 family. Additionally, the family regulates RAS,
MYC, HMAG2, CDC25A, CDK2, and other target genes
that influence a variety of biological phenomena and
physiological processes, especially during biological de-
velopment, cell proliferation and differentiation, andtumor suppression. There are 13 homologs in the let-7
family in the human genome, clustered into eight sites
[45]. These gene clusters are located at fragile sites
related to lung cancer, breast cancer, urothelial cancer,
and cervical cancer, suggesting that they may act as
tumor suppressors. Previous studies of the let-7 family
have largely focused on tumor suppression mechanisms
[46], and studies investigating the family’s role in
growth and development are rare.
The signaling pathway related to the regulation of the
growth and development of skeletal muscle by let-7b-
mediated GHR has not been previously reported. GH
plays important roles in regulating animal growth and
development, and its action on tissues and cells is
mediated through its binding with GHR on the cell sur-
face. GHR is activated upon binding of GH to stimulate
the growth and metabolism of muscle, bone, and cartil-
age cells [3,4]. GH also regulates chicken growth
through close binding to its receptor and activating ex-
pression of IGF. The amount and action of GHR has dir-
ect effect on GH physiological function. In the present
study, the mRNA expression of GHR was significantly
up-regulated in dwarf chickens compared with normal
chickens. The up-regulated mRNA expression of GHR
retarded chicken growth, probably owing to a certain
compensation mechanism [16]. Our data showed that
the retarded growth of dwarf chickens was caused by a
deletion in the GHR 3′ UTR inducing loss of the let-7b
target site. Through signaling pathway analysis, we
found that let-7b regulates the expression of GHR,
and further regulates SOCS3 through the JAK-STAT sig-
naling pathway. Studies have shown that SOCS3 can in-
hibit excessive cell growth and induce apoptosis as part
of maintaining cell stability [47,48]. SOCS3 regulates the
growth and development of chickens through three adi-
pocytokine signaling pathways. (1) SOCS3 inhibits the
tyrosine in IRS1. By inhibiting the phosphorylation of
IRS1, SOCS3 inhibits insulin signaling, thus affecting
growth. (2) SOCS3 inhibits LEPR, and up-regulated
SOCS3 expression in dwarf chickens may affect the func-
tion of leptin. Leptin has a wide range of biological
effects, with an important role in the metabolic regula-
tion center of the hypothalamus, which plays a role in
suppressing appetite, reducing energy intake, increasing
energy expenditure and inhibiting fat synthesis. This
helps explain why dwarf chickens are more likely to
be obese [14]. (3) SOCS3 inhibits JAK; the JAK-
STAT signaling pathway is a recently discovered signal
transduction pathway stimulated by cytokines, and is
involved in cell proliferation, differentiation, apoptosis,
immune regulation, and many other important biological
processes.
In the present study, little change in expression of let-7b
between dwarf and normal chickens was observed;
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chickens, let-7b could not inhibit the expression of GHR.
This allows for the gene to be up-regulated as let-7b is un-
able to pair with GHR gene as its target site is deleted.
Data from the microarray and qPCR analyses supported
that the above pathway, indicating that the expression of
GHR is inhibited by let-7b, and the expression of SOCS3
gene is regulated and stimulated by GHR. Further qPCR
data supported that SOCS3 could inhibit the expression of
IRS1, LEPR and JAK. The expression of IRS1, LEPR and
JAK was significantly down-regulated, expression of genes
regulating skeletal muscle growth (MYOD1, MyoG and
Myf5) and the insulin pathway (IGF1 and IGF2BP3) were
also down-regulated significantly.
Conclusions
A comparison of dwarf chickens with normal chickens at
the same developmental stages revealed that expression
profiles of only a few miRNAs were significantly differ-
ent. In 14-day-old embryos, the expression profiles of a
greater number of miRNAs were significantly different
compared with those in 7-week-old chickens. By com-
bining target gene prediction for differential miRNAs,
joint analysis of mRNA expression profiles, and BLAST
analysis, the critical role of let-7b in regulating the GHR
expression was identified. With the aid of KEGG signal-
ing pathway and qPCR analyses, the network through
which let-7b-mediated GHR regulates growth and devel-
opment of skeletal muscle as well as fat deposition was
established. It was confirmed that SOCS3 plays a critical
role in inhibiting IRS1, LEPR, and JAK.
Methods
Animals
Dwarf and normal recessive White Rock chickens, both
bred for nearly 10 generations, were used. Dwarf chick-
ens had a 1 773-bp deletion mutation at the end of exon
10 and in the 3' UTR of GHR. The two strains were fed
under the same conditions to 7 weeks of age. The weight
of dwarf chickens was about 30% less than that of nor-
mal chickens. Randomly selected embryos of dwarf
chickens and normal chickens were incubated for 14 d,
dissected, and their sex identified according to gonad de-
velopment. Nine female embryos for each chicken strain
were selected for leg muscle separation. Skin and bones
were removed and the muscle divided into three parts.
The divided parts were placed into cryopreservation
tubes then quickly placed into liquid nitrogen (−196°C)
for preservation. Nine dwarf and nine normal chickens,
fed by conventional breeding methods until 7 weeks of
age, were randomly selected, and their leg muscles sepa-
rated. The central muscle of the gastrocnemius was
taken and divided into three parts, placed into cryo-
preservation tubes and quickly placed into liquidnitrogen (−196°C) for preservation. All animal experi-
ments involved in this study were approved by the Ani-
mal Care Committee of South China Agricultural
University (Guangzhou, People's Republic of China).
Chickens were euthanized as necessary to ameliorate
suffering.
Extraction of total RNA
Total RNA was isolated from 0.2 g of skeletal muscle tis-
sues with TRIzolW (Invitrogen Life Technologies, Carlsbad,
CA, USA) according to the manufacturer’s instructions
using an RNeasy MinElute Cleanup Kit. All mRNA was
quantified by spectrophotometry (ND-2000, NanoDrop
Inc., USA). The purity and yield of RNA was deter-
mined using optical density at 260 and 280 nm. RNA
integrity was examined by electrophoresis on a 1.2%
denaturing formaldehyde gel.
Microarray analysis
Three pools of RNA were prepared for each chicken
strain, with each pool containing RNA from three
individuals. The miRNA chips were designed based on
miRNAs listed in miRBase Version 15.0 (http://www.
sanger.ac.uk/Software/Rfam/mirna/), and prepared by
LC Sciences (Houston, Texas, USA). The miRNA
chips used in the present study contained a total of
542 miRNA sequences. Normalization of chip data
was carried out using the Lowess (Locally-weighted
Regression) method [49], and t-tests of the data were
conducted following normalization. Microarray assays
for miRNAs were performed using a service provider
(LC Sciences, Houston, Texas, USA). Raw data were
provided as ceiling exposure limits or Excel files for
subsequent statistical analysis.
Hybridization was performed with 100 μL 6× SSPE buffer
(0.90 M NaCl, 60 mM Na2HPO4, 6 mM EDTA, pH 6.8)
containing 25% formamide at 34°C. Hybridization detection
was facilitated using fluorescent tag-specific Cy3 and Cy5
dyes. Hybridization images were collected using a laser
scanner (GenePix 4000B, Molecular Device) and digitized
using Array-Pro image analysis software (Media Cybernet-
ics). Twelve microarray data were MIAME compliant, and
the raw data were deposited in a database (ArrayExpress,
GEO) with the accession number GSE37360, GSE37367
and GSE37368. Data were analyzed by first subtracting the
background, and then the signals were normalized using a
LOWESS filter.
The raw microarray data set was filtered according
to a standard procedure to exclude spots with mini-
mum intensity. It was arbitrarily set to an intensity
parameter of P300 for mRNA expression data, and
P100 for the miRNA microarray data, on both fluor-
escence channels. If the fluorescence intensity of one
channel was below the cut-off while the other was
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Spots with diameters less than 25 μm for the cDNA
expression array and less than 10 μm for the miRNA
microarray and flagged spots were also excluded from
the analyses. For two color experiments, the ratio of
the two sets of detected signals (log2 transformed,
balanced) and p-values of the t-test were calculated.
Differentially detected signals were those with p-
values less than 0.01. Any false correction tests were
performed for microarray data by qPCR.
The detection of mRNA expression profiles using Affy-
metrix’s Chicken Genechip was completed by the Beijing
Capital Bio Corporation (Beijing, China). The mRNA chip
used in the present study contained a total of 38,535
probes. Each sample had three biological replicates, and
SAM software was used for the analysis of differentially
expressed genes. The screening criteria were as follows:
q-value≤ 5%; with a fold change≥ 2; or a fold change≤ 0.5.
Correlation analysis between miRNA and mRNA
expression profiles
We combined our miRNA expression data and mRNA
expression data to generate a miRNA-mRNA interaction
database using target gene mapping methods and MAS
software. The miRNA and mRNA expression chip
profile-associated analyses combined with network
predictions, estimates the target genes of differentially
expressed miRNAs. To further validate microarray
results, we performed qPCR experiments for representa-
tive genes. The target genes of these miRNAs were iden-
tified by qPCR.
Target gene prediction
TargetScan 5.1 (http://www.targetscan.org/) was used to
carry out target gene prediction for the differentially
expressed miRNA. TargetScan 5.1 proposed the concept
of the ‘seed region’, increasing prediction accuracy, was
the software with the lowest false positive rate for pre-
dicting miRNA targets.
miRNA target gene and mRNA differential expression
profiles
Differentially expressed miRNA prediction target gene sets
were compared with the mRNA differential expression pro-
files from 7-week-old chicken skeletal muscle, and the tar-
get genes affected by miRNA were selected.
Signaling pathway analysis
KEGG is a bioinformatics database established by the
Kanehisa Laboratory of the Japan Kyoto University Bio-
informatics Centre [50,51]. KEGG links genome informa-
tion with gene function, thereby linking genomic and
functional information. In this study, the KEGG PATH-
WAY database (http://www.genome.jp/kegg/) softwareplatform was used for signaling pathway analysis of GHR
regulatory networks.qPCR analysis
Quantitative PCR was used to detect mRNA expres-
sion levels of the major genes in the signaling path-
way. Using published genome sequences, the Primer
Premier 5 software was used for primer design (Add-
itional file 6: Table S4). In the present study, the Ct
value was applied to detect the mRNA expression of
the samples, and three replicates were set for each
sample. The thermal cycling protocol was: 95°C for
1 min, then 40 cycles of 95°C for 15 s, appropriate
annealing temperature for 45 s, and 72°C for 45 s.
The final step after cycling was an extension at 72°C
for 40 s. Melting curve analysis was carried out to deter-
mine the specificity of PCR products. The ΔΔCt method
was used to measure gene expression with β-actin as the
reference gene.Luciferase reporter assays
Based on the data in the miRBase bank (http://www.
mirbase.org/), primers for amplifying pre-let-7b were
designed (Additional file 7: Table S5). PCR products in-
cluding pre-let-7b were ligated and transformed using the
pEASY-T1 Simple Clone Kit (Trans Gen Biotech, Beijing,
China). Two plasmids, pcDNA3.1-EGFP (Invitrogen) and
pEASY-T1-pre-let-7b, were used for constructing the let-
7b expression plasmid pcDNA3.1-EGFP-pre-let-7b. Based
on the data in GenBank, primers for amplifying the GHR
3′ UTR region were designed (Additional file 7: Table S5).
The plasmid pmirGLO-let-7b-GHR 3′ UTR was prepared
for verification of GHR mRNA expression. Two types of
plasmids, the wild-type, and a mutant with GHR deleted
were prepared. Plasmids pcDNA-EGFP-pre-let-7b and
pmirGLO-let-7b-GHR 3′ UTR were co-transfected into
DF-1 cells (3× 104 cells). Validation of GHR as the target
of let-7b, and luciferase reporter assays for functional val-
idation in vitro were conducted. Expression levels of GHR
and other correlated genes were measured using qPCR
analysis in vitro.
Additional filesAdditional file 1: Table S1. The skeletal muscle mRNA differential
profile of 14-day-old embryos and 7-week-old chickens of normal
chickens and dwarf chickens.
Additional file 2: Table S2. The summary table of prediction results of
the differentially expressed.
Additional file 3: Table S3. The intersection genes of the differentially
expressed genes of miRNA target genes and mRNA genes.
Additional file 4: Figure S1. The JAK-STAT signaling pathway with GHR
gene involved in KEGG links the genome information with gene function.
The pathway includes 111 genes in total.
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SOCS3 gene involved in.
Additional file 6: Table S4. Sequences of primers used for qRT-PCR.
Additional file 7: Table S5. Sequences of primers used for vectors
construction.
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